|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2009-07-07 Purchase |
2009-07-09 5:42 pm | Nile Therapeutics, Inc. | NLTX | Kazam Joshua A (Director) | 197,628 | $0 | $0 | 1,278,228 (Direct) | View |
| 2009-03-12 Purchase |
2009-03-13 7:45 pm | Nile Therapeutics, Inc. | NLTX | Kazam Joshua A (Director) | 510 | $0.75 | $382 | 1,080,600 (Direct) |
View |
| 2008-12-16 Purchase |
2008-12-16 9:29 pm |
Nile Therapeutics, Inc. | NLTX | Kazam Joshua A (Director) | 3,100 | $1.15 | $3,565 | 1,080,090 (Direct) |
View |
| 2008-12-15 Purchase |
2008-12-15 8:51 pm | Nile Therapeutics, Inc. | NLTX | Kazam Joshua A (Director) | 2,500 | $1.05 | $2,625 | 1,076,990 (Direct) |
View |
| 2008-12-11- -2008-12-12 Purchase | 2008-12-12 7:25 pm |
Nile Therapeutics, Inc. | NLTX | Kazam Joshua A (Director) | 8,200 | $1.132 | $9,284 | 1,074,490 (Direct) | View |
| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price | Total Amount |
Shares Ownership | Filing |
| 2005-04-01 Option Award | 2005-04-05 4:35 pm |
MANHATTAN PHARMACEUTICALS INC | MHTT | KAZAM JOSHOA A (Director) | 248,827 | $0 | $0 | 492,852 (Direct) | View |
| Transaction & Date | Reported Date | Exercisable Expiration | Company | Symbol | Insider Relationship | Shares Traded | Conversion Price | Shares Ownership |
Filing |
| 2009-07-21 Option Award | 2009-07-23 5:33 pm | 2010-07-21 2019-07-21 | Nile Therapeutics, Inc. | NLTX | Kazam Joshua A (Chief Executive Officer Director) | 65,000 | $1.77 | 65,000 (Direct) |
View |
| 2009-07-15 Other | 2009-07-16 5:11 pm | 2009-07-15 2019-07-15 |
Nile Therapeutics, Inc. | NLTX | Kazam Joshua A (Director) | 31,650 | $1.375 | 31,650 (Direct) |
View |
| 2009-07-07 Purchase |
2009-07-09 5:42 pm | 2009-07-07 2014-07-07 |
Nile Therapeutics, Inc. | NLTX | Kazam Joshua A (Director) | 49,407 | $1.25 | 49,407 (Direct) |
View |
| 2009-07-07 Purchase |
2009-07-09 5:42 pm |
2009-07-07 2014-07-07 |
Nile Therapeutics, Inc. | NLTX | Kazam Joshua A (Director) | 49,407 | $1.71 | 49,407 (Direct) |
View |
| 2009-07-07 Purchase |
2009-07-09 5:42 pm |
2009-07-07 2014-07-07 | Nile Therapeutics, Inc. | NLTX | Kazam Joshua A (Director) | 98,814 | $2.28 | 98,814 (Direct) |
View |
| 2008-12-23 Option Award | 2008-12-23 8:50 pm | N/A 2018-12-22 | Nile Therapeutics, Inc. | NLTX | Kazam Joshua A (Director) | 25,000 | $0.93 | 25,000 (Direct) |
View |
| 2008-05-01 Option Award |
2008-05-02 2:40 pm | N/A 2018-05-01 |
VELCERA, INC. | VLCR | Kazam Joshua A (Director) | 25,000 | $0.9 | 25,000 (Direct) | View |
| 2008-01-25 Option Award |
2008-01-29 6:50 pm | N/A 2018-01-25 |
Nile Therapeutics, Inc. | NILT.OB | Kazam Joshua A (Director) | 50,000 | $4.5 | 50,000 (Direct) | View |
| 2007-05-24 Option Award | 2007-05-29 4:40 pm |
N/A 2017-05-01 |
VELCERA, INC. | None | KAZAM JOSHOA A (Director) | 25,000 | $1.87 | 25,000 (Direct) | View |
| 2005-01-11 Option Award |
2005-03-29 4:20 pm | N/A 2015-01-11 |
MANHATTAN PHARMACEUTICALS INC | MHTT | KAZAM JOSHOA A (Director) | 25,000 | $1 | 25,000 (Direct) |
View |
| 2004-01-27 Other |
2004-02-02 6:01 pm |
2004-01-27 2009-01-27 |
MANHATTAN PHARMACEUTICALS INC | MHTT.OB | KAZAM JOSHOA A (Director) | 60,173 | $1.21 | 85,173 (Direct) | View |
| 2004-01-28 Option Award | 2004-02-02 6:01 pm | N/A 2014-01-27 |
MANHATTAN PHARMACEUTICALS INC | MHTT.OB | KAZAM JOSHOA A (Director) | 75,000 | $1.65 | 85,173 (Direct) | View |
|
© 2005-2010 SecForm4.Com All rights reserved. Archives: 2010 2009 2008 2007 2006 2005 ... Sun, 21 Mar 2010 05:57:39 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |